Search for Clinical Trial Results

Plasma Cell Leukemia - 2 Studies Found
Status | Study |
COMPLETED |
Study Name: Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma Condition: Plasma Cell Leukemia Date: 2025-02-09 Interventions: Undergo autologous peripheral blood stem cell transplant |
COMPLETED |
Study Name: Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma Condition: Plasma Cell Leukemia Date: 2025-02-09 Interventions: Undergo autologous stem cell transplant |